ASH recognizes 10 hematologists with 2024 honorific awards

Yescarta demonstrates improved outcomes for r/r LBCL

Kite announced findings from three new analyses for Yescarta (axicabtagene ciloleucel) that demonstrate improved outcomes for people living with relapsed or refractory large B-cell lymphoma, which were presented at 66th American Society of Hematology annual meeting.

December 13, 2024

Vol.50 No.46

Clinical Roundup

Calquence + Venetoclax shows superior PFS in untreated CLL in AMPLIFY phase III trial

Positive results from the AMPLIFY phase III trial showed AstraZeneca’s Calquence (acalabrutinib) in combination with venetoclax demonstrated a statistically significant and clinically meaningful improvement in progression-free survival compared to standard-of-care chemoimmunotherapy in previously untreated adult patients with chronic lymphocytic leukemia.

December 13, 2024

Vol.50 No.46

In Brief

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

Andrew M. EvensPhillip ScheinbergThe British Journal of Haematology announced the appointment of Andrew M. Evens as its editor-in-chief, effective Jan. 1, 2025.

December 06, 2024

Vol.50 No.45

Drugs & Targets

ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research

ConcertAI announced a joint software-as-a-service solution in hematological malignancies for research analytics, clinical trial design, and clinical trial operational optimization.

December 06, 2024

Vol.50 No.45

In Brief

Thomas Bradley named director of hematology and oncology at Northwell’s Florina Cancer Center

Thomas Bradley has been appointed director of hematology and oncology at Staten Island University Hospital’s Florina Cancer Center to spearhead the division’s clinical, educational, and research initiatives.

October 25, 2024

Vol.50 No.40

In Brief

Michael Seidman joins Fox Chase Department of Hematology/Oncology

Michael Seidman has joined Fox Chase Cancer Center as a professor in the Department of Hematology/Oncology.

August 09, 2024

Vol.50 No.32

ASH recognizes 10 hematologists with 2024 honorific awards

YOU MAY BE INTERESTED IN

Yescarta demonstrates improved outcomes for r/r LBCL

Calquence + Venetoclax shows superior PFS in untreated CLL in AMPLIFY phase III trial

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research

Thomas Bradley named director of hematology and oncology at Northwell’s Florina Cancer Center

Michael Seidman joins Fox Chase Department of Hematology/Oncology

Renew today!

Subscriber content

Never miss an issue!

Login